Geographic variation in access among adults with kidney disease: evidence from medical expenditure panel survey, 2002–2011 (original) (raw)

Abstract

Background: To understand geographic variation in access to care over time in patients with kidney disease. Methods: We analyzed 4404 (weighted sample of 4,251,129) adults with kidney disease from the United States using the Medical Expenditure Panel Survey over 10 years. Three dependent variables were created to investigate variation in access: usual source of care, overall medical access to care, which took into account usual source of care, ability to get care, and delay in care, and prescription access, which took into account ability to get prescriptions and delay in getting prescriptions. Multiple logistic regression was used with geographic region as the main independent variable, adjusting for relevant covariates. Results: Compared to the Northeast region, adults living in the Midwest (OR = 0.56; 95 % CI 0.35-0.89), South (OR = 0. 48; 95 % CI 0.32-0.72) and West (OR = 0.53; 95 % CI 0.34-0.84) had significantly lower odds of reporting usual source of care. For the combined access measure, compared to Northeast, adults in Midwest (OR = 0.60; 95 % CI 0.40-0.88), South (OR = 0.62; 95 % CI 0.44-0.88) and West (OR = 0.50; 95 % CI 0.34-0.72) had significantly lower odds of medical access to care. Region was not significantly associated with the odds of having prescription access, though a significant increase in prescription access was observed over time. Conclusions: Geographic variation in access to care among adults with kidney disease exists independent of income, education, insurance and comorbid conditions, with those in the South least likely to have a usual source of care and those in the West least likely to have overall access to care when compared to the Northeast United States.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (33)

  1. Weinick RM, Drilea SK. Usual sources of health care and barriers to care, 1996. StatBull Metrop Insur Co. 1998;79(1):11-7.
  2. Aday LA and Andersen RM. A framework for the study of access to medical care. Health Services Research. 1974;9(3):208-20.
  3. Andersen RM, Davidson PL. Improving access to care in America: Individual and contextual indicators. In Changing the US Health Care System: Key Issues in Health Services Policy and Management. 3 rd edition. Eds: Andersen RM, Davidson PL, Baumeister SE. San Francisco. Jossey-Bass. 2007. Pages 3-31.
  4. Institute of Medicine (US). Committee on Monitoring Access to Personal Health Care Services. Access to Health Care in America. Ed: M. Millman. Washington DC: National Academy Press. 1993.
  5. Donabedian A. Models for organizing the delivery of personal health services and criteria for evaluating them. Milbank Mem Fund Q. 1972;50:103.
  6. Radley DC, Schoen C. Geographic variation in access to care -the relationship with quality. N Engl J Med. 2012;367(1):3-6.
  7. Comber AJ, Brunsdon C, Radburn R. A spatial analysis of variations in health access: linking geography, socio-economic status and access perceptions. Int J Health Geogr. 2011;10:44.
  8. Williams AW. Health policy, disparities, and the kidney. Adv Chronic Kidney Dis. 2015;22(1):54-9.
  9. Axelrod DA, Lentine KL, Xiao H, et al. Accountability for end-stage organ care: implications of geographic variation in access to kidney transplantation. Surgery. 2014;155(5):734-42.
  10. Mathur AK, Ashby VB, Sands RL, Wolfe RA. Geographic variation in end- stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant. 2010;10(4 Pt 2):1069-80.
  11. Francis A, Didsbury M, Lim WH, et al. The impact of socioeconomic status and geographic remoteness on access to pre-emptive kidney transplantation and transplant outcomes among children. Pediatr Nephrol. 2016;31(6):1011-19.
  12. Hirth RA, Tedeschi PJ, Wheeler JR. Extent and sources of geographic variation in Medicare end-stage renal disease expenditures. Am J Kidney Dis. 2001;38(4):824-31.
  13. Garcia-Garcia G, Jha V. World Kidney Day Steering C. Chronic kidney disease in disadvantaged populations. Transplantation. 2015;99(1):13-6.
  14. Crews DC, Greer RC, Fadrowski JJ, et al. Setting an agenda for comparative effectiveness systematic reviews in CKD care. BMC Nephrol. 2012;13:74.
  15. London R, Solis A, Goldberg GA, Wade S, Chan WW. Examination of resource use and clinical interventions associated with chronic kidney disease in a managed care population. J Manag Care Pharm. 2003;9(3):248-55.
  16. Mohan S, Mutell R, Patzer RE, Holt J, Cohen D, McClellan W. Kidney transplantation and the intensity of poverty in the contiguous United States. Transplantation. 2014;98(6):640-5.
  17. Patzer RE, Pastan SO. Kidney transplant access in the Southeast: view from the bottom. Am J Transplant. 2014;14(7):1499-505.
  18. Shah A, Fried LF, Chen SC, et al. Associations between access to care and awareness of CKD. Am J Kidney Dis. 2012;59(3 Suppl 2):S16-23.
  19. Agency for Healthcare Research and Quality (AHRQa). Methodology Report # 27, Sample design of the 2011 Medical Expenditure Panel Survey Insurance Component 2013a, Available from http://meps.ahrq.gov/data\_ files/publications/mr27/mr27.pdf. Accessed 13 Oct 2016.
  20. Agency for Healthcare Research and Quality (AHRQb). Medical Expenditure Panel Survey. 2011 Full year consolidated data file 2013c, Available from http://meps.ahrq.gov/mepsweb/data\_stats/download\_data\_files.jsp. Accessed 18 Aug 2014.
  21. Agency for Healthcare Research and Quality (AHRQc). MEPS HC-036: 1996- 2011 Pooled Linkage Variance Estimation File 2013d. MEPS file, Available from http://meps.ahrq.gov/data\_stats/download\_data/pufs/h36/h36u11doc. shtml. Accessed 13 Oct 2016.
  22. Agency for Healthcare Research and Quality (AHRQ). Household Component-Insurance Component Linked Data 1999, Research file 2003, Available from http://meps.ahrq.gov/mepsweb/data\_stats/download\_data/ pufs/link_99hcic/hc_ic99link_doc.pdf. Accessed 13 Oct 2016.
  23. Desai PR, Lawson KA, Barner JC, Rascati KL. Identifying patent characteristics associated with high Schizophrenia-related direct medical costs in community-dwelling patents. J Manag Care Pharm. 2013;19(6):468-77.
  24. Ozieh MN, Bishu KG, Dismuke CE, Egede LE. Trends of healthcare expenditure in United States in adults with diabetes: 2002-2011. Diabetes Care. 2015;38(10):1844-51.
  25. Egede LE, Bishu KG, Walker RJ, Dismuke CE. Impact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004-2011. J Affect Disord. 2016;195:119-26.
  26. Archer KJ, Lemeshow S. Goodness-of-fit test for a logistic regression model fitted using survey sample data. Stata J. 2006;6(1):97-105.
  27. Musman S, Passos VMA, Silva IBR, Barreto SM. Evaluation of a prediction model for sleep apnea in patients submitted to polysomnography. J Bras Pneumol. 2011;37(1):75-84.
  28. US Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010.
  29. D. C. Radley, S. K. H. How, A. K. Fryer, D. McCarthy, and C. Schoen, Rising to the Challenge: Results from a Scorecard on Local Health System Performance, 2012, The Commonwealth Fund, March 2012. www. commonwealthfund.org/publications/fund-reports/2012/mar/local- scorecard.
  30. Collins AJ, Chen SC, Gilbertson DT, Foley RN. CKD surveillance using administrative data: impact on the health care system. Am J Kidney Dis. 2009;53(3 Suppl 3):S27-36.
  31. Healthy People 2020 https://www.healthypeople.gov/. Accessed 13 Oct 2016
  32. Sommers BD, Maylone B, Nguyen KH, Blendon RJ, Epstein AM. The Impact Of State Policies On ACA Applications And Enrollment Among Low-Income Adults In Arkansas, Kentucky, And Texas. Health Aff (Millwood). 2015 Jun;34 (6):1010-8.
  33. State Reforum http://www.nashp.org/states-stand-medicaid-expansion- decisions/. Accessed 23 Apr 2016.